Showing results (1241-1250 of 2,458) with videos related to
Sort By:
Pageof 246
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 12, 2024
Middle cerebral artery blood velocity and end-tidal carbon dioxide responses to moderate intensity cycling in children, adolescents, and adultsMax E Weston, Alan R Barker, Owen W Tomlinson, et al.Chemical Communications (Cambridge, England)|June 1, 2016
Creating a hyperpolarised pseudo singlet state through polarisation transfer from parahydrogen under SABREAlexandra M Olaru, Soumya S Roy, Lyrelle S Lloyd, et al.Nature Communications|November 19, 2021
Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobiontsChristopher R Shaler, Alexandra A Parco, Wael Elhenawy, et al.Journal of Proteome Research|June 15, 2005
Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discoveryJohn M Koomen, Donghui Li, Lian-chun Xiao, et al.Pharmaceutical Development and Technology|May 26, 2018
Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasisHevanshi Vidhushika Fernando, Li Li Chan, Nhung Dang, et al.American Heart Journal|October 2, 2001
Tamoxifen is not detrimental to endothelial function in postmenopausal women with breast cancerP J Ong, H Linardou, H A Graham, et al.Clinical Endocrinology|January 1, 1976
Ectopic hormone production by bronchial carcinomas in cultureM L Ellison, C J Hillyard, G A Bloomfield, et al.Journal of Hypertension|June 15, 2007
Pulse pressure amplification during exercise is significantly reduced with age and hypercholesterolemiaJames E Sharman, Carmel M McEniery, Zahid R Dhakam, et al.British Journal of Cancer|August 1, 1990
Aromatase inhibition in advanced prostatic cancer: preliminary communicationR J Shearer, J H Davies, M Dowsett, et al.Molecular Cancer Therapeutics|December 20, 2007
The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cellsJanna Krol, Richard E Francis, André Albergaria, et al.Pageof 246